Hepatology News

Nearly twice as many hepatitis A virus-related deaths were reported in the United States from 2016 to 2022 compared with the previous 6 years, with individuals who use drugs or experience homelessness and unstable housing most at risk.

BOSTON — In this video, John W. Ward, MD, discusses strategies to drive the elimination of hepatitis C virus, including commitment on a national scale.

BOSTON — In this video, John W. Ward, MD, discusses multiple presentations at The Liver Meeting that focused on testing and treatment for hepatitis C virus infection.

BOSTON — In this video, John W. Ward, MD, spoke with Healio about two presentations from The Liver Meeting that highlighted ways to overcome health disparities among patients with hepatitis C virus infection.

BOSTON — LPCN 1148, an oral androgen receptor agonist, improved sarcopenia, hepatic encephalopathy and other biomarkers associated with end-stage liver disease among men with advanced cirrhosis and clinical decompensation.

BOSTON — Treatment of hepatitis C virus infection in low- and middle-income countries is key to global elimination efforts, according to an abstract presented at The Liver Meeting.

BOSTON — Patients with hepatitis C virus-related cirrhosis who achieve sustained virologic response remain at risk for cancer, as well as other non-liver-related events such as diabetes, according to an abstract presented at The Liver Meeting.

As baby boomers age into their 70s and 80s, it is estimated that more than $84 trillion will pass down through inheritances to millennial and Gen X heirs before 2045.

BOSTON — Researchers found “significant gaps” in follow-up testing and treatment among a cohort of pregnant individuals in Canada with a diagnosis of hepatitis C virus infection, according to data presented at The Liver Meeting.

BOSTON — Pegozafermin improved fibrosis and other key noninvasive tests at 24 weeks in patients with metabolic dysfunction-associated steatohepatitis-related cirrhosis, according to data presented at The Liver Meeting.